TY  - RPRT
TI  - FDA perspective on peptide formulation and stability issues.
AU  - C H Niu
AU  - Y Y Chiu
PY  - 1998
DO  - 10.1021/js9800782
UR  - https://pubmed.ncbi.nlm.nih.gov/9811485/
ID  - 9811485
ER  -